Published by Natasha Roberts on 1st February 2012
Mediwatch, a urological diagnostic firm, has reported a rise in pre-tax profit (PTP) up from £0.23m to £0.32m for the year ending October 31st. Sales revenue rose from £10.5m to £10.6m, while cash flow from operations jumped £0.58m to £0.84m. The company attributed the rise in PTP to the re-organisation which began in the first quarter of 2011, as it has enabled the firm to invest in new markets, products and services. The company also saw 75% sales growth in developing markets.